SK69993A3 - 2-amino-n-[[[4-(aminocarbonyl)pyrimidine-2- -yl]amino]alkyl]pyrimidine-4-carboxamide derivatives, process for their preparation and their pharmaceutical compositions - Google Patents

2-amino-n-[[[4-(aminocarbonyl)pyrimidine-2- -yl]amino]alkyl]pyrimidine-4-carboxamide derivatives, process for their preparation and their pharmaceutical compositions Download PDF

Info

Publication number
SK69993A3
SK69993A3 SK699-93A SK69993A SK69993A3 SK 69993 A3 SK69993 A3 SK 69993A3 SK 69993 A SK69993 A SK 69993A SK 69993 A3 SK69993 A3 SK 69993A3
Authority
SK
Slovakia
Prior art keywords
group
amino
pyrimidine
mixture
pyrimidin
Prior art date
Application number
SK699-93A
Other languages
English (en)
Slovak (sk)
Inventor
Pascal George
Benoit Marabout
Jacques Froissant
Jean-Pierre Merly
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9208199A external-priority patent/FR2693195B1/fr
Priority claimed from FR9215037A external-priority patent/FR2699171B1/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of SK69993A3 publication Critical patent/SK69993A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
SK699-93A 1992-07-03 1993-07-02 2-amino-n-[[[4-(aminocarbonyl)pyrimidine-2- -yl]amino]alkyl]pyrimidine-4-carboxamide derivatives, process for their preparation and their pharmaceutical compositions SK69993A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9208199A FR2693195B1 (fr) 1992-07-03 1992-07-03 Dérivés de 2-amino-N-[[[(4-aminocarbonyl)pyrimidin-2-yl]amino]alkyl] pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
FR9215037A FR2699171B1 (fr) 1992-12-14 1992-12-14 Dérivés de 2-amino-N[[[4-aminocarbonyl) pyrimidin-2-yl]amino]alkyl]pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.

Publications (1)

Publication Number Publication Date
SK69993A3 true SK69993A3 (en) 1994-04-06

Family

ID=26229565

Family Applications (1)

Application Number Title Priority Date Filing Date
SK699-93A SK69993A3 (en) 1992-07-03 1993-07-02 2-amino-n-[[[4-(aminocarbonyl)pyrimidine-2- -yl]amino]alkyl]pyrimidine-4-carboxamide derivatives, process for their preparation and their pharmaceutical compositions

Country Status (21)

Country Link
US (1) US5330985A (pl)
EP (1) EP0577470B1 (pl)
JP (1) JP3285421B2 (pl)
KR (1) KR940005619A (pl)
CN (1) CN1100416A (pl)
AT (1) ATE123025T1 (pl)
AU (1) AU660815B2 (pl)
CA (1) CA2099556A1 (pl)
CZ (1) CZ282079B6 (pl)
DE (1) DE69300162T2 (pl)
DK (1) DK0577470T3 (pl)
ES (1) ES2073951T3 (pl)
FI (1) FI933064A7 (pl)
HU (2) HUT65533A (pl)
IL (1) IL106213A (pl)
MX (1) MX9303976A (pl)
NO (1) NO932418L (pl)
NZ (1) NZ248051A (pl)
PL (1) PL172583B1 (pl)
RU (1) RU2111963C1 (pl)
SK (1) SK69993A3 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425143A1 (de) * 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
FR2744722B1 (fr) * 1996-02-14 1998-03-13 Synthelabo Devires de 2-((3-(piperazin-1-yl)propyl)amino)pyrimidine-4- carboxamide et leur application en therapeutique
CA2327543A1 (en) * 1998-05-06 1999-11-11 Duke University Method of treating bladder and lower urinary tract syndromes
WO2006010640A1 (en) * 2004-07-29 2006-02-02 Sanofi-Aventis Pharmaceutical multilayer tablet for controlled release of active ingredients with highly ph-dependent solubility
US9113629B2 (en) * 2013-03-15 2015-08-25 Dow Agrosciences Llc 4-amino-6-(4-substituted-phenyl)-picolinates and 6-amino-2-(4-substituted-phenyl)-pyrimidine-4-carboxylates and their use as herbicides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2618436B1 (fr) * 1987-07-23 1989-10-27 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique
JP2814600B2 (ja) * 1989-08-31 1998-10-22 正幸 石川 排尿障害治療剤
JPH078795B2 (ja) * 1989-09-06 1995-02-01 日立化成工業株式会社 排尿障害治療剤
FR2656609B1 (fr) * 1989-12-28 1992-03-27 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2675799B1 (fr) * 1991-04-24 1993-12-24 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2678271B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2678272B1 (fr) * 1991-06-27 1994-01-14 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
JPH06100545A (ja) 1994-04-12
NZ248051A (en) 1994-10-26
KR940005619A (ko) 1994-03-21
FI933064A0 (fi) 1993-07-02
DE69300162T2 (de) 1995-11-02
HU211462A9 (en) 1995-11-28
NO932418D0 (no) 1993-07-02
IL106213A (en) 1998-02-22
RU2111963C1 (ru) 1998-05-27
CZ135193A3 (en) 1994-02-16
EP0577470B1 (fr) 1995-05-24
PL299541A1 (en) 1994-01-10
AU4171293A (en) 1994-01-06
FI933064L (fi) 1994-01-04
MX9303976A (es) 1994-02-28
FI933064A7 (fi) 1994-01-04
NO932418L (no) 1994-01-04
JP3285421B2 (ja) 2002-05-27
DE69300162D1 (de) 1995-06-29
HUT65533A (en) 1994-06-28
CN1100416A (zh) 1995-03-22
CZ282079B6 (cs) 1997-05-14
US5330985A (en) 1994-07-19
HU9301937D0 (en) 1993-09-28
DK0577470T3 (da) 1995-10-02
AU660815B2 (en) 1995-07-06
CA2099556A1 (en) 1994-01-04
ES2073951T3 (es) 1995-08-16
PL172583B1 (pl) 1997-10-31
IL106213A0 (en) 1993-11-15
EP0577470A1 (fr) 1994-01-05
ATE123025T1 (de) 1995-06-15

Similar Documents

Publication Publication Date Title
US20190010161A1 (en) Crystalline form of btk kinase inhibitor and preparation method thereof
US5210086A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their use in therapy
US5244901A (en) 4-pyrimidinecarboxamide derivatives, their preparation and their application in therapy
AU644295B2 (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics
HUT65177A (en) Process for producing antitumor activity enhancing pyrimidine derivatives and pharmaceutical preparations containing them
US5229392A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparaton and their application in therapy
CN104876879B (zh) 一种bcr-abl激酶抑制剂
CZ135193A3 (en) Derivatives of 2 amino-n-{/£4-(aminocarbonyl)pyrimidin-2-yl|amino/alkyl} pyrimidine-4-carboxamide, process of their preparation and pharmaceutical preparations in which they are comprised
US5254560A (en) 2-piperidinylpyrimidine-4-carboxamide derivatives, and their use in therapeutics
IE53613B1 (en) Spirothiazolidinyl piperazine derivatives
RU2128176C1 (ru) Производные 2-аминопиразин-5-карбоксамида, способ их получения и содержащие их медицинский препарат и фармацевтическая композиция
CZ9202001A3 (en) 2-aminopyrimidine-4-carboxamide derivatives, process of their preparation and pharmaceutical compositions in which said derivatives are comprised
JPH06211809A (ja) ２−アミノピリミジン−４−カルボキサミド誘導体
FR2699171A1 (fr) Dérivés de 2-amino-N[[[4-aminocarbonyl) pyrimidin-2-yl]amino]alkyl]pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
PL182402B1 (pl) Nowe pochodne piperazyny, sposób ich otrzymywania oraz zawierające je środki farmaceutyczne